SPON2 and glioblastoma: demonstrated that miR-497-5p effectively suppressed the expression of SPON2 in glioblastoma (GBM) tumors, thereby inhibiting the WNT/β-catenin signaling pathway and subsequently reducing cellular metastasis (7).